Indivior Pharmaceuticals (INDV) Liabilities and Shareholders Equity (2023 - 2026)
Indivior Pharmaceuticals' Liabilities and Shareholders Equity came in at $1.23 billion for Q2 2026, down 15.1% from $1.45 billion a year earlier but up 3.0% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends
At the end of FY2025, Indivior Pharmaceuticals' Liabilities and Shareholders Equity was $1.2 billion, down 8.7% from FY2024.
- Going back by year, Liabilities and Shareholders Equity was $1.32 billion in FY2024 (-25.1%) and $1.76 billion in FY2023.
- The five-year range for quarterly Liabilities and Shareholders Equity is $1.2 billion (Q1 2026) to $1.76 billion (Q4 2023).
- Year-over-year, Liabilities and Shareholders Equity has declined for three consecutive quarters, with an average decline of 15.5% over the last four quarters.
- Business Quant data shows INDV's Liabilities and Shareholders Equity at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025) and $1.42 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Indivior Pharmaceuticals | 4.23 Bn | 3.19 Bn | 294.00 Mn | 1.23 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.23 Bn |
| Mar 31, 2026 | 1.20 Bn |
| Dec 31, 2025 | 1.20 Bn |
| Sep 30, 2025 | 1.42 Bn |
| Jun 30, 2025 | 1.45 Bn |
| Mar 31, 2025 | 1.38 Bn |
| Dec 31, 2024 | 1.32 Bn |
| Dec 31, 2023 | 1.76 Bn |
API Access
Indivior Pharmaceuticals Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();